Insulet
Trade Insulet 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PODD
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals.
PODD Key Statistics
Stock Snapshot
With a market cap of 19.9B, Insulet(PODD) trades at $282.89. The stock has a price-to-earnings ratio of 80.71.
On 2026-01-14, Insulet(PODD) stock moved within a range of $275.10 to $284.25. With shares now at $282.89, the stock is trading +2.8% above its intraday low and -0.5% below the session's peak.
Trading activity shows a volume of 781.78K, compared to an average daily volume of 650.52K.
Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $354.88 and a low of $230.05.
Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $354.88 and a low of $230.05.
PODD News
Barclays analyst Matt Miksic downgraded Insulet (PODD) to Underweight from Equal Weight with a price target of $274, down from $316. As new competition approach...